The authors identify the lack of specific biomarkers as a key research gap that needs addressing for personalized treatment strategies. Without these biomarkers, clinicians cannot effectively diagnose or monitor the unique pathophysiological context of depression in AD. Gap type: open_question Source paper: Neurobiological and therapeutic landmarks of depression associated with Alzheimer's disease dementia. (2025, Frontiers in aging neuroscience, PMID:40529210)
Landscape Summary: What specific biomarkers can distinguish depression-AD comorbidity from either condition alone? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What specific biomarkers can distinguish depression-AD comorbidity from either condition alone? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: